Department of Health and Social Care

NHS England has a National Clinical Director for Cardiovascular Disease (CVD) Prevention.

We are committed to reducing premature mortality from heart disease and stroke by 25% in the next ten years and are prioritising ambitious, evidence-led and clinically informed approaches to CVD prevention and care to tackle one of the country’s biggest killers head-on.

To accelerate progress towards this ambition, we will publish a CVD Modern Service Framework (CVD MSF) later this year. The framework will support consistent, high quality and equitable care whist fostering innovation across the CVD pathway. The Department and NHS England are engaging widely with stakeholders to co-produce the CVD MSF, ensuring that experts, people and communities are at the heart of its development.

Currently, adults become eligible for their shingles vaccination when they turn 65 or 70 years of age, and they remain eligible until their 79th birthday. Adults who are severely immunosuppressed, and therefore most at risk of serious illness and complications from shingles, are eligible from 18 years old and do not have an upper age limit.

The shingles vaccination programme has been in place since 2013, and therefore there will be a significant portion of adults currently aged 80 years old and over who were offered, and received, Zostavax, the previous shingles vaccine. All those who were born after 1 September 1933 would have been offered a vaccine in the programme.

In November 2024, the Joint Committee on Vaccination and Immunisation provided advice to the Government on eligibility for the shingles vaccination programme. This included advice that the Government should consider expanding the shingles vaccination offer to include older adult cohorts aged 80 years old and over. The Government is carefully considering this advice as it sets the policy on who should be offered shingles vaccinations in the future.

As set out in the 10-Year Health Plan, to accelerate progress on the ambition to reduce premature deaths from heart disease and stroke by 25% within a decade, we will publish a new cardiovascular disease modern service framework (CVD MSF) later this year.

The Department and NHS England are engaging widely with stakeholders to co-produce the CVD MSF, ensuring that experts, people, and communities are at the heart of its development. These frameworks will identify the best evidenced interventions that would support progress towards this goal, with a focus on those with the best means to drive up value and equity. Furthermore, they will set standards on how those interventions should be used, alongside a clear strategy to support and oversee uptake by clinicians and providers.

The Government welcomes the Health Innovation Network (HIN) Impact Report 2024/25, and the network's focus on cardiovascular disease as a strategic priority. We recognise the significant impact of the HINs in driving innovation into the National Health Service, benefitting 4.9 million patients and leveraging £3 billion of investment since 2018. This is why the Government’s 10-Year Health Plan and the Life Sciences Sector Plan make explicit commitments to continue funding and empowering them.

As set out in the 10-Year Health Plan, to accelerate progress on the ambition to reduce premature deaths from heart disease and stroke by 25% within a decade, we will publish a new cardiovascular disease modern service framework later this year.

Whilst there is an increasing move towards digital National Health Service communications, NHS letters remain crucial for many patients, particularly those who may be digitally excluded, therefore, they will always be included in the screening offer. For bowel screening, NHS England currently uses NHS Notify which sends pre-invitations via the NHS App first, and if that message isn't read or the person doesn't have the app, a paper letter is sent. Everyone will still get sent a bowel cancer screening home testing kit through the post after pre-information, with information on completing the kit.

National roll out of digital pre-invitations is planned over the next couple of months, following a regional pilot last year. From that pilot, NHS England saw approximately 30% of people receive these communications via the NHS app. Based on other similar services, NHS England expects this to increase when other digital communications such as SMS are introduced.

National rollout has already been completed in cervical screening with positive results, where approximately 90% of invites are received via the NHS App or SMS.

Impact on the uptake of screening will be monitored over at least a six-month period to allow people time to take up their screening offer. To date, no negative impact has been indicated, but NHS England is monitoring closely to assess.

The Tobacco and Vapes Bill, currently being considered in the House of Lords, provides powers for ministers in England, Wales, and Northern Ireland to introduce a licensing scheme, in their respective nations, for the retail sale of tobacco, vapes, and nicotine products. This will strengthen enforcement and support legitimate businesses, while acting as a deterrent to retailers who breach the law. In doing so, it will support public health.

We recently launched a call for evidence to gather views on a range of topics related to tobacco, vapes, and nicotine products, including the proposed licensing scheme. The call for evidence ran for eight weeks and closed in December 2025. The evidence gathered will be used to inform the development of the licensing scheme, and we will launch a subsequent consultation on our policy proposals before bringing forward secondary legislation.

As set out in the 10-Year Health Plan for England, we are taking decisive action on the obesity crisis to shift the focus from treatment to prevention and ease the strain on our National Health Service, including in Slough.

We have fulfilled our commitment to restrict junk food advertising targeted at children on television and online. We have also implemented restrictions on volume price promotions for less healthy food and drink, such as three for the price of two offers, and consulted on our proposals to ban the sale of high-caffeine energy drinks to children aged under 16 years old.

We will go further by introducing mandatory reporting on the healthiness of sales for all large food businesses and setting new healthier food targets. We will also strengthen the existing advertising and promotions restrictions by applying an updated definition of ‘less healthy food and drink’. We published the updated Nutrient Profiling Model in January, ahead of consulting on its policy application.

To support people already living with obesity, we will double the number of patients able to access the NHS Digital Weight Management Programme. From June 2025, the NHS began making weight loss drugs available through primary care. Approximately 220,000 adults will be considered in the first three years with access prioritised by clinical need. We are committed to expanding NHS access and will work closely with industry and local systems to identify innovative ways to do this.

Officials in the Office for Health Improvement and Disparities’ South East team work closely with local partners including local authorities and the NHS to support them with local initiatives to promote a healthy lifestyle and to tackle obesity.

The National Cancer Plan, published on 4 February 2026, sets out clear actions to expand diagnostic genomic testing and ensure that this is matched by access to targeted therapies. The plan confirms that every cancer patient who would benefit from genomic testing, including those with rare cancers, will receive it within a clinically relevant timeframe.

To support timely access to treatments identified through genomic testing, a new joint National Institute for Health and Care Excellence and Medicines and Healthcare products Regulatory Agency process from April 2026 will accelerate licensing and appraisal so that National Health Service funding recommendations can be made more quickly. The expansion of the NHS Genomic Medicine Service will also help identify suitable targeted therapies, connect patients to clinical trials faster, and integrate genomic data into the Single Patient Record by 2028.

With reference to page 75 of the National Cancer Plan, it is Government policy that patients with rare cancers should benefit from personalised and targeted therapies where genomic testing identifies a suitable option. The plan also strengthens specialist multidisciplinary teams for rare cancers so that patients can access expertise from specialist centres and the most up‑to‑date evidence‑based treatments.

The National Cancer Plan, published on 4 February 2026, sets out clear actions to expand diagnostic genomic testing and ensure that this is matched by access to targeted therapies. The plan confirms that every cancer patient who would benefit from genomic testing, including those with rare cancers, will receive it within a clinically relevant timeframe.

To support timely access to treatments identified through genomic testing, a new joint National Institute for Health and Care Excellence and Medicines and Healthcare products Regulatory Agency process from April 2026 will accelerate licensing and appraisal so that National Health Service funding recommendations can be made more quickly. The expansion of the NHS Genomic Medicine Service will also help identify suitable targeted therapies, connect patients to clinical trials faster, and integrate genomic data into the Single Patient Record by 2028.

With reference to page 75 of the National Cancer Plan, it is Government policy that patients with rare cancers should benefit from personalised and targeted therapies where genomic testing identifies a suitable option. The plan also strengthens specialist multidisciplinary teams for rare cancers so that patients can access expertise from specialist centres and the most up‑to‑date evidence‑based treatments.

The Department monitors geographic inequalities in cancer diagnosis and treatment through the NHS Cancer Waiting Time Standards, for which data is published at integrated care board and provider level. The NHS England Acute Provider Table for all 134 providers supports this transparency.

Early diagnosis is monitored through NHS England’s annual publication of early diagnosis data in England, the Case-mix Adjusted Percentage of Cancers Diagnosed at Stages 1 and 2. Early diagnosis data is published for England as a whole and for the integrated care boards. Survival data is monitored through NHS England's annual publication of cancer survival data in England. Cancer survival data is published for England as a whole, for the National Health Service regions, integrated care boards, and Cancer Alliances for 21 selected cancers. The index of cancer survival for all cancers is published for England, integrated care boards, and Cancer Alliances.

The Department recognises that outcomes remain poorest in some deprived, rural and coastal areas, where rates of early diagnosis and cancer survival are lower. To support improvement, the Government has provided £200 million of ring‑fenced funding for Cancer Alliances in 2026/27 to help the lowest‑performing trusts strengthen diagnostic pathways and reduce delays.

The Department monitors progress through regular oversight with NHS England, tracking improvements in early diagnosis and treatment standards across regions. These measures underpin our commitment to reducing geographic disparities so that a patient’s chances of survival do not depend on where they live.

NHS England’s updated Specialised Neurology Service Specification, published in August 2025, includes specific reference to functional neurological disorder (FND). It states that all specialised neurology centres must include access to treatment services for FND. The updated Specialised Neurology Service Specification is available at the following link:

https://www.england.nhs.uk/publication/specialised-neurology-services-adults/

There are a number of other national-level initiatives supporting service improvement and better care for patients with neurological conditions, including FND, such as the Getting It Right First Time Programme for Neurology and the Neurology Transformation Programme, which aim to improve care for people by reducing variation and delivering care more equitably across England.

Additionally, we have set up a UK Neuro Forum facilitating formal, which are twice-yearly meetings across the Department, NHS England, the devolved administrations and health services, and the Neurological Alliances of all four nations. The new forum brings key stakeholders together, to share learning across the system and to discuss challenges, best practice examples, and potential solutions for improving the care of people with neurological conditions, including FND.

The National Cancer Plan sets out how we will strengthen the cancer workforce, including for diagnostics, such as pathology. The plan sets out sustainable workforce growth, focused not on simply expanding numbers but on ensuring staff are properly trained, supported, and able to work at the top of their skills.

The plan sets out how we will support pathologists to work more efficiently through a £604 million investment in digital diagnostics, including digital pathology, and £96 million in the automation of histopathology, as well as further investment in digital technology and artificial intelligence. Expansion of advanced clinical practice for scientists will also improve the efficiency and effectiveness of the pathology workforce as a whole.

The 10 Year Workforce Plan will be published in spring, setting out further action to create a workforce able to deliver the transformed service set out in the 10-Year Health Plan.

Through our National Health Service screening programmes, we can reduce mortality and morbidity from cancer in the population who appear healthy and have no symptoms, by detecting conditions at an earlier, more treatable stage. Each year, over 15 million people are invited for screening, with over 10 million taking up the invitation.

In Birmingham and Solihull, between 2022/23 and 2023/24 there has been an improvement of 4.93% in breast cancer screening uptake in 53 to 70 year old people.

In Sutton Coldfield, the breast screening is offered to all eligible cohorts in line with service specifications of the NHS Breast Screening Programme. In this constituency, uptake and coverage are stable and constituents can access screening at both static and mobile facilities. There is a dedicated focus on reducing health inequalities, supporting access, and informing eligible patients to actively take up their screening appointment and offer.

The breast screening service in Sutton Coldfield is currently undertaking a targeted text messaging initiative targeting eligible patients that have not attended their screening invitation. This includes the offer to rebook their screening appointment and a link to bilingual breast screening videos to support education and awareness. A follow-up text message survey is also being used to explore barriers to attendance and motivating factors, with insights informing ongoing service development.

Other initiatives to increase uptake in the area include:

• a dedicated general practice toolkit to support and inform health promotion messaging;

• a breast screening resource pack for care homes to support staff in promoting screening awareness and facilitating uptake amongst eligible residents; and

• a cancer bus initiative promoting a range of services including breast cancer screening.

The Government is committed to tackling child poverty and to raising the healthiest generation of children ever. Our Children, Our Future: Tackling Child Poverty was published on 5 December 2025 and set out a goal to reduce and alleviate the impact of child poverty, with urgent action to improve the lives of children in deepest poverty.

We recognise the significant financial and practical pressures faced by low-income families when a child with a long-term condition requires hospital care. To support eligible low-income families with the costs associated with repeated or prolonged hospital stays, the NHS Healthcare Travel Costs Scheme provides support with the cost of travelling to hospital appointments.

In addition, many hospitals work with charitable partners, such as Ronald McDonald House Charities, to provide free or low-cost accommodation close to specialist children’s hospitals, helping parents stay near their child during treatment.

The NHS Business Services Authority is the administrator of the Vaccine Damage Payment Scheme (VDPS). The following table shows the total number of awarded claims in each financial year since 2021/22:

Note: Data for 2025/26 figure is accurate as of 6 February 2026. The previous question, answered on 28 October 2025, covered the period up until 30 September 2025. Some claims may be paid in a different financial year to which they were awarded.

The Government recognises that there are stark inequalities for women and babies, and that they should receive the high-quality care they deserve, regardless of their background, location, or ethnicity.

Baroness Amos is chairing the National Independent Maternity and Neonatal Investigation which aims to identify the drivers and impact of inequalities faced by women, babies, and families from Black and Asian backgrounds, as well as deprived and marginalised groups.

The Government is committed to setting an explicit target to close the maternal mortality gap. We are ensuring that we take an evidence-based approach to determining what targets are set, and that any targets set are women and baby-centred.

NHS England’s Perinatal Equity and Anti-Discrimination Programme aims to ensure that all service users and their families receive care that is free from discrimination and racism. Local Maternity and Neonatal Systems have published Equity and Equality action plans containing evidence-based interventions to support women and families from ethnic minority backgrounds or economically deprived areas. NHS England also launched the Maternal Care Bundle that sets clear standards across all services, focused on the main causes of maternal death and harm. The Maternal Care Bundle is avaiable on the NHS.UK website. Women from Black and Asian backgrounds are more at risk of specific clinical conditions that are the leading causes of death. This bundle targets these conditions, and we expect a decline in deaths and harm.

NHS England is responsible for determining allocations of financial resources to integrated care boards (ICBs), informed by a target formula to determine the ‘fair share’ of total funding available for each ICB. NHS England published allocations for ICBs covering 2026/27 to 2028/29 in November 2025, with further information available at the following link:

https://www.england.nhs.uk/publication/allocation-of-resources-2026-27-to-2027-28/

Following a meeting with West Mercia Police about the detail and schedule of their ongoing investigation, Baroness Amos concluded that the Shrewsbury and Telford Hospital NHS Trust should be removed from the National Maternity and Neonatal Investigation.

Leeds Teaching Hospitals NHS Trust was removed from the list of trusts under review as part of the national investigation following my Rt Hon. Friend, the Secretary of State for Health and Social Care’s decision to commission a separate independent maternity inquiry on 20 October.

The Call for Evidence for the National Maternity and Neonatal Investigation was launched in January 2026, and the investigation has encouraged families in Shrewsbury and Telford, and Leeds to participate.

On 26 January 2026, the Independent Maternity and Neonatal Investigation launched a Workforce Call for Evidence. This is open specifically to all those who work in the maternity and neonatal care pathway and is a separate to the public call for evidence. It takes the form of a short online survey and focuses on the experiences of staff delivering care across the maternity and neonatal pathway and how best to support teams to provide high-quality, safe, and compassionate care. Findings will inform the investigation’s national recommendations, due for publication in spring 2026.

Information about how to access the workforce survey has been distributed to all NHS trusts and the investigation is asking them to cascade the link to all maternity and neonatal staff groups. It is currently live and will be open for six weeks, closing on 9 March 2026.

Baroness Amos is also meeting the senior team in each of the 12 trusts and staff panels are also being held on site.

A list of leaders for national organisations, including statutory, Arm’s Length Bodies, and the voluntary and charitable sector, is being developed by the National Maternity and Neonatal Investigation. Leaders of these organisations will be invited to a formal interview with the Chair, Director of investigation, and a member of the Expert Panel.

The National Maternity and Neonatal Investigation is also gathering evidence from organisations. Organisations and other individuals, for instance researchers, wishing to submit evidence to the investigation can submit this directly by email to the investigation mailbox. The deadline for all evidence submissions is 17 March 2026.

Following a meeting with West Mercia Police about the detail and schedule of their ongoing investigation, Baroness Amos concluded that the Shrewsbury and Telford Hospital NHS Trust should be removed from the National Maternity and Neonatal Investigation.

Leeds Teaching Hospitals NHS Trust was removed from the list of trusts under review as part of the national investigation following my Rt Hon. Friend, the Secretary of State for Health and Social Care’s decision to commission a separate independent maternity inquiry on 20 October.

The Call for Evidence for the National Maternity and Neonatal Investigation was launched in January 2026, and the investigation has encouraged families in Shrewsbury and Telford, and Leeds to participate.

On 26 January 2026, the Independent Maternity and Neonatal Investigation launched a Workforce Call for Evidence. This is open specifically to all those who work in the maternity and neonatal care pathway and is a separate to the public call for evidence. It takes the form of a short online survey and focuses on the experiences of staff delivering care across the maternity and neonatal pathway and how best to support teams to provide high-quality, safe, and compassionate care. Findings will inform the investigation’s national recommendations, due for publication in spring 2026.

Information about how to access the workforce survey has been distributed to all NHS trusts and the investigation is asking them to cascade the link to all maternity and neonatal staff groups. It is currently live and will be open for six weeks, closing on 9 March 2026.

Baroness Amos is also meeting the senior team in each of the 12 trusts and staff panels are also being held on site.

A list of leaders for national organisations, including statutory, Arm’s Length Bodies, and the voluntary and charitable sector, is being developed by the National Maternity and Neonatal Investigation. Leaders of these organisations will be invited to a formal interview with the Chair, Director of investigation, and a member of the Expert Panel.

The National Maternity and Neonatal Investigation is also gathering evidence from organisations. Organisations and other individuals, for instance researchers, wishing to submit evidence to the investigation can submit this directly by email to the investigation mailbox. The deadline for all evidence submissions is 17 March 2026.

Following a meeting with West Mercia Police about the detail and schedule of their ongoing investigation, Baroness Amos concluded that the Shrewsbury and Telford Hospital NHS Trust should be removed from the National Maternity and Neonatal Investigation.

Leeds Teaching Hospitals NHS Trust was removed from the list of trusts under review as part of the national investigation following my Rt Hon. Friend, the Secretary of State for Health and Social Care’s decision to commission a separate independent maternity inquiry on 20 October.

The Call for Evidence for the National Maternity and Neonatal Investigation was launched in January 2026, and the investigation has encouraged families in Shrewsbury and Telford, and Leeds to participate.

On 26 January 2026, the Independent Maternity and Neonatal Investigation launched a Workforce Call for Evidence. This is open specifically to all those who work in the maternity and neonatal care pathway and is a separate to the public call for evidence. It takes the form of a short online survey and focuses on the experiences of staff delivering care across the maternity and neonatal pathway and how best to support teams to provide high-quality, safe, and compassionate care. Findings will inform the investigation’s national recommendations, due for publication in spring 2026.

Information about how to access the workforce survey has been distributed to all NHS trusts and the investigation is asking them to cascade the link to all maternity and neonatal staff groups. It is currently live and will be open for six weeks, closing on 9 March 2026.

Baroness Amos is also meeting the senior team in each of the 12 trusts and staff panels are also being held on site.

A list of leaders for national organisations, including statutory, Arm’s Length Bodies, and the voluntary and charitable sector, is being developed by the National Maternity and Neonatal Investigation. Leaders of these organisations will be invited to a formal interview with the Chair, Director of investigation, and a member of the Expert Panel.

The National Maternity and Neonatal Investigation is also gathering evidence from organisations. Organisations and other individuals, for instance researchers, wishing to submit evidence to the investigation can submit this directly by email to the investigation mailbox. The deadline for all evidence submissions is 17 March 2026.

A New Vision for Water sets out that public health will be considered in new water frameworks and regulations. This will support delivery of shared outcomes, like those in the 10-Year Health Plan, which commits to assessing the further rollout of water fluoridation in areas where oral health outcomes are worst. We will also expand community water fluoridation in the north east of England from 2028 so that it reaches 1.6 million more people by April 2030. We will also refurbish older, existing water fluoridation schemes in England, benefitting a further six million people by 2030.

The membership of the National Maternity and Neonatal Taskforce is currently being finalised. The first meeting of the taskforce will be held in early spring.

The taskforce will publish a national action plan to drive improvements across maternity and neonatal care in due course, following publication of Baroness Amos’ independent investigation’s final report and recommendations.

The Department, NHS England, and the Nursing Midwifery Council are urgently working to ensure that midwifery training consistently delivers modern maternity care that respects a woman’s choice and individual circumstances.

We will introduce a new set of standards for modern employment in April 2026 to deliver our ambition to make the National Health Service the best place to work. We are committed to tackling the retention and recruitment challenges that face the NHS. As of November 2025, there were 25,530 full time equivalent midwives working in NHS trusts and other core organisations in England. This is an increase of 824, or 3.3%, compared to November 2024. We are also investing over £149 million through the 2025/26 Estates Safety Fund to address critical safety risks on the maternity estate, enabling better care for mothers and their newborns.

In addition, Baroness Amos is leading an independent investigation into NHS maternity and neonatal care. This includes understanding the experience of staff and healthcare professionals delivering care at all stages of the maternity and neonatal care pathway and how they can best be supported in providing high-quality, safe, and compassionate care. My Rt Hon. Friend, the Secretary of State for Health and Social Care, will chair a maternity and neonatal taskforce that will address the recommendations of the investigation by developing a national action plan to drive improvements across maternity and neonatal care.

It is the responsibility of the commissioner to ensure patients registered with a general practice (GP) have access to urgent care when they are at home and unable to attend the practice they are registered with.

Under the GP Contract, GPs are required to provide services to a patient outside of practice premises, for instance via a home visit, in instances where the practice considers that a consultation is required, and it would be inappropriate for the patient to attend the practice.

Commonly, a patient is considered housebound if they cannot leave their home environment due to physical or psychological illness.

The Mental Capacity Act 2005 (MCA) is designed to protect and empower people who lack the mental capacity to make a decision themselves. It says that every person must be presumed to have capacity to make the decision in question unless it is established otherwise, and sets out a two-stage test to establish if a person can make specific decisions regarding their care and treatment. Capacity assessments are done locally, and data is not collated or held centrally on how many assessments are carried out.

The Deprivation of Liberty Safeguards (DoLS) is a procedure prescribed in law under the MCA when a person who lacks mental capacity to consent to their care or treatment is being deprived of their liberty in a care home or hospital in order to keep them safe from harm. DoLS assessments data is collated and published, the most recent data available is for 2023/24.

In 2023/24 there were 323,870 DoLS applications completed, 145,945 fully assessed, 15,270 closed partially assessed, 162,655 closed without assessments, and 123,790 not completed at year end.

The MCA code of practice gives guidance to people who work with, or care for, people who can’t make decisions for themselves, including when a mental capacity assessment should be carried out, and by whom. Government is clear that professionals applying the MCA are expected to keep up to date with guidance and caselaw, and to correctly use the principles within the act.

In October 2025 we announced our intention to run a joint consultation with the Ministry of Justice to consult on Liberty Protection Safeguards and an updated draft of the Code of Practice in 2026.

The Mental Capacity Act 2005 (MCA) is designed to protect and empower people who lack the mental capacity to make a decision themselves. It says that every person must be presumed to have capacity to make the decision in question unless it is established otherwise, and sets out a two-stage test to establish if a person can make specific decisions regarding their care and treatment. Capacity assessments are done locally, and data is not collated or held centrally on how many assessments are carried out.

The Deprivation of Liberty Safeguards (DoLS) is a procedure prescribed in law under the MCA when a person who lacks mental capacity to consent to their care or treatment is being deprived of their liberty in a care home or hospital in order to keep them safe from harm. DoLS assessments data is collated and published, the most recent data available is for 2023/24.

In 2023/24 there were 323,870 DoLS applications completed, 145,945 fully assessed, 15,270 closed partially assessed, 162,655 closed without assessments, and 123,790 not completed at year end.

The MCA code of practice gives guidance to people who work with, or care for, people who can’t make decisions for themselves, including when a mental capacity assessment should be carried out, and by whom. Government is clear that professionals applying the MCA are expected to keep up to date with guidance and caselaw, and to correctly use the principles within the act.

In October 2025 we announced our intention to run a joint consultation with the Ministry of Justice to consult on Liberty Protection Safeguards and an updated draft of the Code of Practice in 2026.

In 2026/27, and as per the Medium Term Planning Framework – delivering change together 2026/27 to 2028/29, all integrated care boards and community health services providers must identify and act on productivity opportunities, including ensuring teams have the digital tools and equipment they need to connect remotely to health systems and patients, and expanding point-of-care testing in the community.

Through the Community Health Services Data Plan (2024/25-2026/27), work is underway to improve the quality, relevance, and timeliness of community health service data and, in turn, improve the patient experience in community health services.

In addition, our 10-Year Health Plan will help put services at the heart of the community and expand digital tools to manage health, including through the Single Patient Record. It will give patients real control over a single, secure, and authoritative account of their data and enable more coordinated, personalised, and predictive care. It will improve clinical outcomes, make decision-making more informed, and speed up the delivery of care.

By law, all health and social care services must have a procedure for dealing efficiently with complaints, and anyone who has seen or experienced poor-quality care has the right to complain to the organisation that provided or paid for the care.

Telecare is not a mandatory service for local authorities, but many choose to provide a telecare service due to its benefits. Some local authorities will also fully or partially fund telecare for some individuals based on a financial assessment. Local authorities are responsible for the contractual terms of telecare services that they provide, therefore in the first instance an individual should consider making a complaint with the relevant local authority.

If an individual is not satisfied with the way a local authority has dealt with their complaint, they may escalate it to the Local Government and Social Care Ombudsman who can investigate individual concerns. The Local Government and Social Care Ombudsman is the independent complaints lead for adult social care and investigates complaints from those receiving social care.

We have provided a £125 million capital funding boost for eligible adult, and children and young people’s, hospices in England to ensure they have the best physical environment for care.

The Government is developing a Palliative Care and End-of-Life Care Modern Service Framework (MSF) for England. We will consider contracting and commissioning arrangements as part of our MSF. We recognise that there is currently a mix of contracting models in the hospice sector. By supporting integrated care boards (ICBs) to commission more strategically, we can move away from grant and block contract models. In the long term, this will aid sustainability and help hospices’ ability to plan ahead.

Officials are working closely with a number of stakeholders from the hospice sector in the development of the MSF.

Additionally, the recently published Medium-Term Planning Guidance and the Model ICB Blueprint set out that ICBs should act as strategic commissioners with core functions including: understanding current and projected total service utilisation and costs; identifying underserved communities; assessing quality, performance, and productivity of existing provision; and significantly reducing avoidable unplanned hospital admissions.

Modern service frameworks will define an aspirational, long-term outcome goal for a major condition and then identify the best evidenced interventions and the support for delivery. Early priorities will include cardiovascular disease, severe mental illness, and the first ever service framework for frailty and dementia.

The Government will consider other long-term conditions for future waves of modern service frameworks, including respiratory conditions. The criteria for determining other conditions for future modern service frameworks will be based on where there is potential for rapid and significant improvements in quality of care and productivity. After the initial wave of MSFs is complete, the National Quality Board will determine the conditions to prioritise for new MSFs as part of its work programme.

The Government will consider long-term conditions for future waves of modern service frameworks (MSFs), including respiratory conditions. The criteria for determining other conditions for future MSFs will be based on where there is potential for rapid and significant improvements in quality of care and productivity. After the initial wave of MSFs is complete, the National Quality Board will determine the conditions to prioritise for new MSFs as part of its work programme. There has not, therefore, been a specific assessment made in relation to winter pressures.

NHS England and the Department of Health and Social Care are working with the Department for Science, Innovation and Technology to explore innovation and policy prioritisation in respiratory health, including the cross‑Government alignment that may be required.

Data is available for emergency Finished Admission Episodes (FAEs) where there was a primary diagnosis of 'respiratory conditions’. The following table shows the number of emergency FAEs where there was a primary diagnosis of respiratory conditions, for activity in English National Health Service hospitals and English NHS commissioned activity in the independent sector, for Mid Harrow and England, for 2024/25 and 2025/26:

Source: Hospital Episode Statistics, NHS England.

Available data on trends in respiratory conditions can be found on the Department’s Fingertips dataset. Data is not available by parliamentary constituency. Data is available at regional, county, unitary authority, and integrated care board level. Information for the London Borough of Harrow can be found at the following link:

https://fingertips.phe.org.uk/search/respiratory#page/1/gid/1/pat/15/ati/502/are/E09000015/iid/40701/age/163/sex/4/cat/-1/ctp/-1/yrr/1/cid/4/tbm/1

NHS England, working with the Department, the UK Health Security Agency, and other partners, is taking action to reduce the impact of respiratory conditions on the NHS this winter. Further details of the actions being taken to reduce demand on acute services during winter is available at the following link:

https://www.england.nhs.uk/long-read/urgent-and-emergency-care-plan-2025-26/

The Government will consider long-term conditions for future waves of modern service frameworks (MSFs), including respiratory conditions. The criteria for determining other conditions for future MSFs will be based on where there is potential for rapid and significant improvements in quality of care and productivity. After the initial wave of MSFs is complete, the National Quality Board will determine the conditions to prioritise for new MSFs as part of its work programme. There has not, therefore, been a specific assessment made in relation to winter pressures.

NHS England and the Department of Health and Social Care are working with the Department for Science, Innovation and Technology to explore innovation and policy prioritisation in respiratory health, including the cross‑Government alignment that may be required.

Data is available for emergency Finished Admission Episodes (FAEs) where there was a primary diagnosis of 'respiratory conditions’. The following table shows the number of emergency FAEs where there was a primary diagnosis of respiratory conditions, for activity in English National Health Service hospitals and English NHS commissioned activity in the independent sector, for Mid Harrow and England, for 2024/25 and 2025/26:

Source: Hospital Episode Statistics, NHS England.

Available data on trends in respiratory conditions can be found on the Department’s Fingertips dataset. Data is not available by parliamentary constituency. Data is available at regional, county, unitary authority, and integrated care board level. Information for the London Borough of Harrow can be found at the following link:

https://fingertips.phe.org.uk/search/respiratory#page/1/gid/1/pat/15/ati/502/are/E09000015/iid/40701/age/163/sex/4/cat/-1/ctp/-1/yrr/1/cid/4/tbm/1

NHS England, working with the Department, the UK Health Security Agency, and other partners, is taking action to reduce the impact of respiratory conditions on the NHS this winter. Further details of the actions being taken to reduce demand on acute services during winter is available at the following link:

https://www.england.nhs.uk/long-read/urgent-and-emergency-care-plan-2025-26/

The Government will consider long-term conditions for future waves of modern service frameworks (MSFs), including respiratory conditions. The criteria for determining other conditions for future MSFs will be based on where there is potential for rapid and significant improvements in quality of care and productivity. After the initial wave of MSFs is complete, the National Quality Board will determine the conditions to prioritise for new MSFs as part of its work programme. There has not, therefore, been a specific assessment made in relation to winter pressures.

NHS England and the Department of Health and Social Care are working with the Department for Science, Innovation and Technology to explore innovation and policy prioritisation in respiratory health, including the cross‑Government alignment that may be required.

Data is available for emergency Finished Admission Episodes (FAEs) where there was a primary diagnosis of 'respiratory conditions’. The following table shows the number of emergency FAEs where there was a primary diagnosis of respiratory conditions, for activity in English National Health Service hospitals and English NHS commissioned activity in the independent sector, for Mid Harrow and England, for 2024/25 and 2025/26:

Source: Hospital Episode Statistics, NHS England.

Available data on trends in respiratory conditions can be found on the Department’s Fingertips dataset. Data is not available by parliamentary constituency. Data is available at regional, county, unitary authority, and integrated care board level. Information for the London Borough of Harrow can be found at the following link:

https://fingertips.phe.org.uk/search/respiratory#page/1/gid/1/pat/15/ati/502/are/E09000015/iid/40701/age/163/sex/4/cat/-1/ctp/-1/yrr/1/cid/4/tbm/1

NHS England, working with the Department, the UK Health Security Agency, and other partners, is taking action to reduce the impact of respiratory conditions on the NHS this winter. Further details of the actions being taken to reduce demand on acute services during winter is available at the following link:

https://www.england.nhs.uk/long-read/urgent-and-emergency-care-plan-2025-26/

The Government will consider long-term conditions for future waves of modern service frameworks (MSFs), including respiratory conditions. The criteria for determining other conditions for future MSFs will be based on where there is potential for rapid and significant improvements in quality of care and productivity. After the initial wave of MSFs is complete, the National Quality Board will determine the conditions to prioritise for new MSFs as part of its work programme. There has not, therefore, been a specific assessment made in relation to winter pressures.

NHS England and the Department of Health and Social Care are working with the Department for Science, Innovation and Technology to explore innovation and policy prioritisation in respiratory health, including the cross‑Government alignment that may be required.

Data is available for emergency Finished Admission Episodes (FAEs) where there was a primary diagnosis of 'respiratory conditions’. The following table shows the number of emergency FAEs where there was a primary diagnosis of respiratory conditions, for activity in English National Health Service hospitals and English NHS commissioned activity in the independent sector, for Mid Harrow and England, for 2024/25 and 2025/26:

Source: Hospital Episode Statistics, NHS England.

Available data on trends in respiratory conditions can be found on the Department’s Fingertips dataset. Data is not available by parliamentary constituency. Data is available at regional, county, unitary authority, and integrated care board level. Information for the London Borough of Harrow can be found at the following link:

https://fingertips.phe.org.uk/search/respiratory#page/1/gid/1/pat/15/ati/502/are/E09000015/iid/40701/age/163/sex/4/cat/-1/ctp/-1/yrr/1/cid/4/tbm/1

NHS England, working with the Department, the UK Health Security Agency, and other partners, is taking action to reduce the impact of respiratory conditions on the NHS this winter. Further details of the actions being taken to reduce demand on acute services during winter is available at the following link:

https://www.england.nhs.uk/long-read/urgent-and-emergency-care-plan-2025-26/

Of the 16 schemes in Wave 1 of the New Hospital Programme (NHP), the Derriford Emergency Care Hospital commenced construction in October 2025. Poole Hospital and the remaining stages of Brighton 3Ts hospital (for the Sussex Cancer Centre) are in the pre-construction period and are expected to enter main construction later this year.

The remaining 13 schemes continue to progress to main construction commencing as set out in the plan for implementation, available at the following link:

https://www.gov.uk/government/publications/new-hospital-programme-review-outcome/new-hospital-programme-plan-for-implementation

NHS England does not hold this information centrally. Integrated care boards have contractual powers to manage activity by providers, which were enhanced in 2025/26 with central support for setting and managing activity. The NHS Standard Contract includes the ability to set indicative action plans to help providers and commissioners plan demand, capacity, and expenditure. While not binding, if activity exceeds the agreed plan, and therefore the funding agreed, an Activity Management Plan can be agreed to bring activity back in line.

I refer the Hon. Member to the answer I gave to the Hon. Member for Rushcliffe on 20 November 2025 to Question 89688.

Reducing waiting lists is a key part of the Government’s Health Mission, and we are committed to cutting waiting times across all specialities, including gynaecology. We have committed to return to the National Health Service constitutional standard, that 92% of patients wait no longer than 18 weeks from referral to treatment, by March 2029. We are making good progress, as waiting lists have been cut by over 310,000 since the Government came into office, which includes almost 20,000 patients waiting for gynaecology treatment over the same period.

Our Elective Reform Plan, published in January 2025, set out the reforms we are making to improve gynaecology waiting times, across England. This includes innovative models of care that offer care closer to home and in the community, piloting gynaecology pathways in community diagnostic centres for patients with post-menopausal bleeding, and increasing the relative funding available to incentivise providers to take on more gynaecology procedures. It also includes expanding the number of surgical hubs, which provide valuable and protected capacity across elective specialities, including gynaecology. Currently, over half of the 125 operational elective surgical hubs in England provide gynaecology services. Wider elective reforms will help cut waiting times for gynaecology services, including more consistent clinical triage, tackling missed appointments, and scaling up remote monitoring and use of patient-initiated follow ups. We are also introducing an “online hospital”, through NHS Online. From 2027, people on certain pathways, including severe menopause symptoms and menstrual problems that may be a sign of endometriosis or fibroids, will have the choice of getting the specialist care they need from their home, providing additional appointments to cut waiting times.

Reducing waiting lists is a key part of the Government’s Health Mission, and we are committed to cutting waiting times across all specialities, including gynaecology. We have committed to return to the National Health Service constitutional standard, that 92% of patients wait no longer than 18 weeks from referral to treatment, by March 2029. We are making good progress, as waiting lists have been cut by over 310,000 since the Government came into office, which includes almost 20,000 patients waiting for gynaecology treatment over the same period.

Our Elective Reform Plan, published in January 2025, set out the reforms we are making to improve gynaecology waiting times, across England. This includes innovative models of care that offer care closer to home and in the community, piloting gynaecology pathways in community diagnostic centres for patients with post-menopausal bleeding, and increasing the relative funding available to incentivise providers to take on more gynaecology procedures. It also includes expanding the number of surgical hubs, which provide valuable and protected capacity across elective specialities, including gynaecology. Currently, over half of the 125 operational elective surgical hubs in England provide gynaecology services. Wider elective reforms will help cut waiting times for gynaecology services, including more consistent clinical triage, tackling missed appointments, and scaling up remote monitoring and use of patient-initiated follow ups. We are also introducing an “online hospital”, through NHS Online. From 2027, people on certain pathways, including severe menopause symptoms and menstrual problems that may be a sign of endometriosis or fibroids, will have the choice of getting the specialist care they need from their home, providing additional appointments to cut waiting times.

In order to increase survival rates from out-of-hospital cardiac arrest, NHS England has worked in partnership with St John’s Ambulance and others to increase access to cardiopulmonary resuscitation (CPR) training. Local ambulance trusts, charities including St John’s Ambulance, the British Heart Foundation, and private providers deliver CPR training and the use of defibrillators both in the community and in schools, under the Restart a Heart programme.

The Government’s position is that local communities are best placed to make decisions about procuring, locating and maintaining automated external defibrillators (AEDs). Over 110,000 defibrillators are registered in the United Kingdom on The Circuit, the independent AED database. Over 30,000 of these have been added in the past two years, many as a result of local community led action.

The Government will consider long-term conditions for future waves of modern service frameworks (MSFs), including respiratory conditions. The criteria for determining other conditions for future MSFs will be based on where there is potential for rapid and significant improvements in the quality of care and productivity. After the initial wave of MSFs is complete, the National Quality Board will determine the conditions to prioritise for new MSFs as part of its work programme.

Provisional data is available for emergency Finished Admission Episodes (FAEs) where there was a primary diagnosis of 'respiratory conditions’. The following table shows the number of emergency FAEs with a primary diagnosis of respiratory conditions for Epsom and Ewell and for England, for activity in English National Health Service hospitals and English NHS commissioned activity in the independent sector, for 2024/25 and 2025/26:

Source: Hospital Episode Statistics, NHS England.

Available data on trends in respiratory conditions can be found on the Department’s Fingertips dataset. Data is not available by parliamentary constituency. Data is available at regional, county, unitary authority, and integrated care board level. Information for Surrey can be found at the following link:

https://fingertips.phe.org.uk/search/respiratory#page/1/gid/1/pat/15/ati/502/are/E10000030/iid/40701/age/163/sex/4/cat/-1/ctp/-1/yrr/1/cid/4/tbm/1

The Government has committed to delivering three big shifts that our NHS needs to be fit for the future: from hospital to community; from analogue to digital; and from sickness to prevention. All of these are relevant to improving respiratory health in all parts of the country.

Through our community diagnostic centres, we are building capacity for respiratory testing and enabling people to get diagnosed closer to home. 101 community diagnostic centres across the country now offer out of hours services, 12 hours a day, seven days a week, meaning patients can access vital diagnostic tests around busy working lives. This is alongside action being taken to expand capacity and improve the quality of pulmonary rehabilitation services to support patients living with respiratory conditions.

NHS England’s Operational Planning Guidance for 2025/26 set a target that, by the end of March 2026, 65% of patients wait no longer than 18 weeks.

To achieve this, we expect the size of the total waiting list to reduce and have already made significant progress. As of November 2025, the waiting list had reduced by over 312,000 since the Government came into office. This is despite 30.1 million referrals onto the waiting list. Performance against the referral to treatment standard had improved by 2.9% over the same period, reaching 61.8%.

This has been supported by the delivery of 5.2 million additional appointments between July 2024 and June 2025 compared to the previous year, more than double the Government’s pledge of two million. This marks a vital first step towards delivering the constitutional standard.

We set out in the 10-Year Health Plan for England that over the next three years, we will create 1,000 new specialty training posts, with a focus on specialties where there is greatest need. We will set out next steps in due course.

The Government is committed to training the staff we need, including doctors, to ensure patients are cared for by the right professional, when and where they need it. We will publish a 10 Year Workforce Plan to set out action to create a workforce ready to deliver the transformed services set out in the 10-Year Health Plan.

The Government will consider long-term conditions for future waves of modern service frameworks (MSFs), including respiratory conditions. The criteria for determining other conditions for future MSFs will be based on where there is potential for rapid and significant improvements in the quality of care and productivity. After the initial wave of MSFs is complete, the National Quality Board will determine the conditions to prioritise for new MSFs as part of its work programme.

The Department holds data on emergency Finished Admission Episodes (FAEs) where there was a primary diagnosis of respiratory condition for Poole and England, for activity from August 2024 to November 2025, although the data is provisional. The following table shows the number of emergency FAEs with a primary diagnosis of respiratory condition, for Poole and England, for activity in English National Health Service hospitals and English NHS commissioned activity in the independent sector, from August 2024 to November 2025:

Source: Hospital Episode Statistics, NHS England.

Available data on trends in respiratory conditions can be found on the Department’s Fingertips dataset. Data is not available by parliamentary constituency. Data is available at a regional, county, unitary authority, and integrated care board level. Information for Dorset is available at the following link:

https://fingertips.phe.org.uk/search/respiratory#page/1/gid/1/pat/15/ati/502/are/E06000059/iid/40701/age/163/sex/4/cat/-1/ctp/-1/yrr/1/cid/4/tbm/1

The Government has committed to delivering the three big shifts that our NHS needs to be fit for the future: from hospital to community; from analogue to digital; and from sickness to prevention. All of these are relevant to improving respiratory health in all parts of the country.

Through our community diagnostic centres, we are building capacity for respiratory testing and enabling people to get diagnosed closer to home. 101 community diagnostic centres across the country now offer out of hours services, 12 hours a day, seven days a week, meaning patients can access vital diagnostic tests around busy working lives. This is alongside action being taken to expand capacity and improve the quality of pulmonary rehabilitation services to support patients living with respiratory conditions.